Distinct roles for the complement regulators factor H and Crry in protection of the kidney from injury

Jennifer Laskowski1, Brandon Renner1, Moglie Le Quintrec2

  • 1Department of Medicine, University of Colorado School of Medicine, Aurora, CO, USA.

Insights

Complement regulatory proteins factor H and Crry protect kidneys from injury. Combined deletion surprisingly led to milder renal injury due to widespread complement activation limiting C3 deposition.

Area of Science:

  • Immunology
  • Nephrology

Background:

  • Mutations in complement regulatory proteins (CRPs) are linked to various diseases.
  • Dysregulated alternative pathway (AP) activation often targets kidneys due to limited CRP expression on renal surfaces.

Purpose of the Study:

  • To investigate the roles of factor H (fH) and Crry in protecting distinct renal surfaces from AP-mediated injury.
  • To understand how combined genetic deletions of fH and Crry impact renal injury.

Main Methods:

  • Generated mice with targeted deletions of the genes for factor H and Crry.
  • Assessed renal injury and C3 deposition in mice with single or combined fH and Crry deficiencies.

Main Results:

  • Mice with combined fH and Crry deletions showed significantly milder renal injury compared to fH-deficient mice.
  • Combined deficiency led to C3 deposition in multiple kidney locations, but lower glomerular C3 deposition than fH deficiency alone.

Conclusions:

  • Factor H and Crry are crucial for regulating complement AP activation at specific renal anatomic sites.
  • Widespread AP activation, even when detrimental, can reduce local injury by depleting C3 pools.

Related Concept Videos

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in...
334
Continuous Renal Replacement Therapy01:30

Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
1.7K
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
8.4K
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
4.3K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K